A detailed history of Silvercrest Asset Management Group LLC transactions in Natera, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 94,635 shares of NTRA stock, worth $10.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
94,635
Previous 155,343 39.08%
Holding current value
$10.1 Million
Previous $9.73 Million 11.05%
% of portfolio
0.06%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$59.21 - $92.9 $3.59 Million - $5.64 Million
-60,708 Reduced 39.08%
94,635 $8.66 Million
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $880,998 - $1.47 Million
23,462 Added 17.79%
155,343 $9.73 Million
Q3 2023

Nov 14, 2023

SELL
$43.4 - $62.52 $5,772 - $8,315
-133 Reduced 0.1%
131,881 $5.84 Million
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $914,387 - $1.07 Million
19,422 Added 17.25%
132,014 $6.42 Million
Q1 2023

May 15, 2023

BUY
$36.57 - $58.29 $4.12 Million - $6.56 Million
112,592 New
112,592 $6.25 Million
Q2 2021

Aug 16, 2021

SELL
$86.05 - $119.72 $5.9 Million - $8.21 Million
-68,613 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$91.47 - $124.36 $2.36 Million - $3.21 Million
-25,843 Reduced 27.36%
68,613 $6.97 Million
Q4 2020

Feb 16, 2021

SELL
$66.66 - $111.74 $3.98 Million - $6.67 Million
-59,675 Reduced 38.72%
94,456 $9.4 Million
Q3 2020

Nov 16, 2020

SELL
$45.89 - $72.67 $1.47 Million - $2.33 Million
-32,114 Reduced 17.24%
154,131 $11.1 Million
Q2 2020

Aug 14, 2020

BUY
$26.36 - $49.86 $721,947 - $1.37 Million
27,388 Added 17.24%
186,245 $9.29 Million
Q1 2020

May 15, 2020

BUY
$17.27 - $40.17 $849,424 - $1.98 Million
49,185 Added 44.85%
158,857 $4.74 Million
Q4 2019

Feb 14, 2020

BUY
$32.1 - $40.4 $3.52 Million - $4.43 Million
109,672 New
109,672 $3.7 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.